MedBrain Global, founded in 2022, has made a promising entry into the Health Care sector by providing an offline, AI-powered clinical assistant designed to support healthcare professionals in low and middle-income nations.
With the slogan, "Reliable diagnostic support for healthcare professionals working in low and middle-income nations," MedBrain operates from its headquarters in Spain, focusing on transforming diagnostic practices in under-resourced settings. The solution is already operational in 50 health centers in Ethiopia, with expansion plans targeting both Ethiopia and Nigeria. They aim to reach over 1 million patient diagnoses monthly by 2026.
Having received its latest investment from Ship2B during a Pre Seed Round on 20 March 2023, MedBrain's clinical accuracy has been validated through government-led trials, demonstrating its potential to close the global diagnostic gap with a scalable model poised for national deployment.